siRNA, Anti-FBXL7, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT36762WQ-2OMe)

The product SIRGT36762WQ-2OMe is a type of small interfering RNA (siRNA) that targets FBXL7 gene and regulates the expression of gene. The siRNA interferes with the expression of FBXL7 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001278317.1
Alternative Names FBL6; FBL7
Related Diseases Van Maldergem Syndrome
Purification HPLC
Target Gene
Gene ID 23194
Uniprot ID Q9UJT9
Sub Cat Target Species Modification Scale  
SIRGT37762WQ-2F FBXL7 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT38762WQ-2MOE FBXL7 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT39762WQ-LNA FBXL7 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT36762WQ-RB FBXL7 Human Ribo-modified Inquiry
SIRGT37762WQ-BB FBXL7 Human Backbone-modified Inquiry

Related Products